CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,785,602
- in 2 filings, $14.7M under 10b5-1 plans
Net −$17,785,602. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-08 | Lewis William Chair and CEO | Exercise or conversion | +24,977 | $4.55 | $114K | 24,977 |
| 2022-08-08 | Lewis William Chair and CEO | Sale | −24,977 | $28.43 | $710K | 0 |
| 2022-08-08 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) | −30,630 | 0 | ||
| 2022-08-08 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) | −186,170 | 0 | ||
| 2022-07-12 | Smith Michael Alexander General Counsel, Senior VP | Sale | −941 | $23.40 | $22K | 50,455 |
| 2022-07-07 | Lewis William Chair and CEO | Exercise or conversion | +96,614 | $16.16 | $1.6M | 353,330 |
| 2022-07-07 | Lewis William Chair and CEO | Sale | −96,614 | $23.00 | $2.2M | 256,716 |
| 2022-07-07 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) | −96,614 | 0 | ||
| 2022-05-23 | Wise John Drayton Chief Commercial Officer | Grant or award | +26,236 | 78,137 | ||
| 2022-05-23 | Wise John Drayton Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +164,580 | 164,580 | ||
| 2022-05-17 | Smith Michael Alexander General Counsel, Senior VP | Sale | −1,055 | $20.37 | $21K | 50,583 |
| 2022-05-17 | Lewis William Chair and CEO | Sale | −5,996 | $20.18 | $121K | 255,828 |
| 2022-05-17 | Adsett Roger Chief Operating Officer | Sale | −2,022 | $20.34 | $41K | 145,982 |
| 2022-05-17 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale | −1,670 | $20.27 | $34K | 68,822 |
| 2022-05-16 | Smith Michael Alexander General Counsel, Senior VP | Sale | −433 | $18.48 | $8K | 51,638 |
| 2022-05-16 | Lewis William Chair and CEO | Sale | −3,398 | $18.35 | $62K | 261,824 |
| 2022-05-16 | Bonstein Sara Chief Financial Officer | Sale | −1,433 | $18.51 | $27K | 54,683 |
| 2022-05-16 | Adsett Roger Chief Operating Officer | Sale | −1,394 | $18.45 | $26K | 148,004 |
| 2022-05-16 | Flammer Martina M.D. Chief Medical Officer | Sale | −1,574 | $18.51 | $29K | 66,432 |
| 2022-05-16 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale | −1,114 | $18.41 | $21K | 70,492 |
Page 51 of 54 · 1,061 trades